Matches in Wikidata for { <http://www.wikidata.org/entity/Q82928805> ?p ?o ?g. }
Showing items 1 to 45 of
45
with 100 items per page.
- Q82928805 description "article scientifique publié en 2008" @default.
- Q82928805 description "artículu científicu espublizáu n'avientu de 2008" @default.
- Q82928805 description "im Dezember 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82928805 description "scientific article published on 01 December 2008" @default.
- Q82928805 description "wetenschappelijk artikel" @default.
- Q82928805 description "наукова стаття, опублікована в грудні 2008" @default.
- Q82928805 name "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 name "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 type Item @default.
- Q82928805 label "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 label "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 prefLabel "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 prefLabel "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 P1433 Q82928805-D5261A1C-7657-4346-AD2A-A84222EADD8B @default.
- Q82928805 P1476 Q82928805-C9583D8D-F2FD-40C2-ACA3-40674AF149BD @default.
- Q82928805 P2093 Q82928805-122BDA16-6CB1-4CF3-B63C-5938BB775E93 @default.
- Q82928805 P2093 Q82928805-48C3BB65-2C24-4E39-A12B-AA88C4DA0F2D @default.
- Q82928805 P2093 Q82928805-6F4A022F-736E-442D-9312-C723A0A7543B @default.
- Q82928805 P2093 Q82928805-9F73B99B-ED30-4D5B-BF60-45D528E59D9F @default.
- Q82928805 P304 Q82928805-59E040D5-495B-4CA0-8D11-5CC6723DEE24 @default.
- Q82928805 P31 Q82928805-8A41E2C0-10FF-4F55-AE3F-8D0403F11BF2 @default.
- Q82928805 P356 Q82928805-1BB5B9F2-9FB6-41D7-8CA3-3CA90DC220D6 @default.
- Q82928805 P433 Q82928805-FD6D2420-B3CD-49C3-B9DF-184A31CFB7C1 @default.
- Q82928805 P478 Q82928805-348F878E-A79B-47E6-887E-DB477905EAAD @default.
- Q82928805 P50 Q82928805-A690A5BE-3EEB-4D45-A7E6-480604993701 @default.
- Q82928805 P577 Q82928805-41B854A5-FC40-4135-8DB7-6AA48B77417F @default.
- Q82928805 P698 Q82928805-0506C255-6E02-4D23-BF9A-4B0A292CF20C @default.
- Q82928805 P921 Q82928805-6E193528-C442-4B21-AB2F-BB41E6EB63CD @default.
- Q82928805 P356 ARCHDERMATOL.2008.510 @default.
- Q82928805 P698 19075161 @default.
- Q82928805 P1433 Q15749524 @default.
- Q82928805 P1476 "Eczematous dermatitis in the setting of hyper-IgE syndrome successfully treated with omalizumab" @default.
- Q82928805 P2093 "Alexandra Paravisini" @default.
- Q82928805 P2093 "Eduardo Fernandez-Cruz" @default.
- Q82928805 P2093 "José Antonio Avilés-Izquierdo" @default.
- Q82928805 P2093 "Susan Bard" @default.
- Q82928805 P304 "1662-1663" @default.
- Q82928805 P31 Q13442814 @default.
- Q82928805 P356 "10.1001/ARCHDERMATOL.2008.510" @default.
- Q82928805 P433 "12" @default.
- Q82928805 P478 "144" @default.
- Q82928805 P50 Q73199599 @default.
- Q82928805 P577 "2008-12-01T00:00:00Z" @default.
- Q82928805 P698 "19075161" @default.
- Q82928805 P921 Q55787700 @default.